News

The European Patent Office (EPO) upholds bit.bio's patent for its dual genomic safe harbour technology, opti-ox™, securing the bro...

The list looks at how companies are performing and what they are working on.

Today we celebrate Stem Cell Awareness Day and salute all of our peers working to realise the therapeutic potential of stem cell-d...

bit.bio's ioSensory Neurons pain research was selected for presentation at SfN’s Neuroscience 2024 press conference.

bit.bio Wins Honours for Innovation in Synthetic Biology and Exceptional Business Growth.

bit.bio appoints new Chief Financial Officer, Przemek Obloj

bit.bio launches panel of 16 neurodegenerative disease models for research and drug discovery in Alzheimer’s and Parkinson’s disea...

Presenting our first annual sustainability report, detailing our Corporate Sustainability Strategy and progress towards our aligne...